Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic Assessment Study, Single Site and Prospective, comparing18F-DOPA PET and Multiparametric RMI in Initial Exploration of Diffuse Glial Tumors

NCT03525080 is registered in ClinicalTrials.gov with Center Eugene Marquis as lead sponsor.

NCT NCT03525080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03525080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic Assessment Study, Single Site and Prospective, comparing18F-DOPA PET and Multiparametric RMI in Initial Exploration of Diffuse Glial Tumors
Lead sponsor
Center Eugene Marquis
Phase
Not applicable
Overall status
Completed
Start date
June 12, 2018
Completion date
September 11, 2019
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult brain tumor, brain neoplasms